---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-120194"
form_type: "8-K"
ticker: "AGIO"
cik: "0001439222"
company_name: "AGIOS PHARMACEUTICALS, INC."
filed_at: "2022-04-26T23:59:59+00:00"
generated_at: "2026-06-26T04:36:39.085953+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Ian T. Clark resigns from Agios board effective after 2022 annual meeting

## Summary
- Ian T. Clark resigns as director effective immediately following the 2022 annual meeting.
- Clark also steps down from Compensation & People and Nominating & Corporate Governance committees.
- Company states resignation not related to any disagreement over operations, policies, or practices.
- No replacement director announced as of April 25, 2022.

## SEC filing metadata
- accession: 0001193125-22-120194
- form_type: 8-K
- ticker: AGIO
- cik: 0001439222
- company_name: AGIOS PHARMACEUTICALS, INC.
- filed_at: 2022-04-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439222/000119312522120194/0001193125-22-120194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439222/000119312522120194/d335110d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-120194
- JSON: https://secwatch.observer/filing/0001193125-22-120194.json
- Plain text: https://secwatch.observer/filing/0001193125-22-120194.txt

## Key facts
- Executive change
  Ian T. Clark resigned as Director at AGIOS PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Director
  source text: On April 25, 2022, Ian T. Clark notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board, effective immediately following the 2022 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312522120194/0001193125-22-120194-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.